The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Seven & i Holdings Co Ltd
SWB:S6M
|
JP |
|
Orrstown Financial Services Inc
NASDAQ:ORRF
|
US |
|
Global Industrial Co
F:GML0
|
US |
|
C
|
Conn's Inc
SWB:CN4
|
US |
|
thyssenkrupp AG
F:TKA
|
DE |
|
D
|
DocuSign Inc
SWB:DS3
|
US |
|
S
|
SD Biotechnologies Co Ltd
KOSDAQ:217480
|
KR |
|
BDO Unibank Inc
OTC:BDOUF
|
PH |
|
P
|
Petro Matad Ltd
OTC:PRTDF
|
MN |
|
A
|
Atlas Arteria Group
F:M82
|
AU |
|
I
|
Impact Silver Corp
XMUN:IKL
|
CA |
|
O
|
Omnicell Inc
F:OC9
|
US |
|
Imago Mulia Persada Tbk PT
IDX:LFLO
|
ID |
|
C
|
Conagra Brands Inc
LSE:0I2P
|
US |
|
A
|
ASML Holding NV
DUS:ASME
|
NL |
|
M
|
Mitsubishi Electric Corp
F:MIE1
|
JP |
|
L
|
Lundin Mining Corp
XMUN:GXD
|
CA |
|
B
|
Basic Net SpA
MIL:BAN
|
IT |
|
Imuraya Group Co Ltd
TSE:2209
|
JP |
|
Afya Ltd
F:1AY
|
BR |
|
S
|
Sumitomo Corp
DUS:SUMA
|
JP |
|
MariMed Inc
OTC:MRMD
|
US |
|
L
|
LivsMed Inc
KOSDAQ:491000
|
KR |
|
Colefax Group PLC
LSE:CFX
|
UK |
Seven & i Holdings Co Ltd (S6M)’s 12-month stock price forecast through October 2027 has a consensus target of €12.564, implying 14% upside. The forecast is based on price targets from 20 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
S6M is 12.564 EUR with a low forecast of 7.634 EUR and a high forecast of 17.637 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is 0%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 3 years is -7%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 1 year is -13%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 0%.
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is -1%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more